Biopharma stocks had a mixed bag in 2024, showing some surprising shifts amidst challenges. The iShares Biotechnology ETF, renowned as the largest of its kind,
Biopharma stocks had a mixed bag in 2024, showing some surprising shifts amidst challenges. The iShares Biotechnology ETF, renowned as the largest of its kind,